

The Chain: Protein Engineering Podcast
Cambridge Healthtech Institute
The Chain explores the lives, careers, research, and discoveries of protein engineers and scientists, the impact their work is having on the field, and where the industry is headed. Tune in to stay up-to-date on the newest advancements and to hear the stories that are impacting the world of biologics.
Episodes
Mentioned books

Oct 15, 2019 • 8min
Episode 05: Hot Topics in Continuous Chromatography for Protein Purification w/ Dr. Massimo Morbidelli
Dr. Massimo Morbidelli is giving the Keynote Presentation in the “Protein Purification Technologies” conference that’s part of CHI’s 11th annual PEGS Summit Europe in Lisbon Portugal. Dr. Morbidelli is an internally recognized expert in protein purification, and shares his insights about continuous processing, its applications, challenges and future outlooks.Continuous countercurrent chromatography is recognized as the technology of choice for a number of instances in the area of protein purification. Approaching its maturity stage, this technology has to be reconsidered with respect to crucial aspects for its future development. In particular, we discuss issues related to scalability in the GMP environment, model-based process characterization and validation, as well as process automation, control and digitalization particularly in the context of continuous integrated manufacturing.

Oct 1, 2019 • 11min
Episode 04: Toward in silico Lead Discovery – the Advent of AI and Machine Learning w/ Lars Linden, PhD, Head, Protein Biochemistry, Biologics Research, Bayer
Dr. Lars Linden will be presenting during the Optimisation & Developability conference at PEGS Europe Summit, November 18-22, in Lisbon, Portugal. He speaks with CHI on August 6, 2019 to share his current responsibilities and how they have and will continue to evolve, especially with AI and machine learning in the horizon.Topics discussed include how developability assessments, combined with in silico assays and in vitro high throughput methods, are able to rank candidates quickly in discovery, to advance the best ones to lead optimization and help select the right molecules. This is especially useful with today’s myriad molecules from bi- to multi-specifics to different types of conjugates. Dr Linden further discusses the role and impact of AI and machine learning to accelerate and simplify drug discovery, and better predict and optimise molecules throughout the R&D value chain.

Sep 17, 2019 • 9min
Episode 03: Science Stories and the Return of Cell-Free Synthesis with Dr. Marco Casteleijn
Over fifty years since its first use, Dr. Marco Casteleijn breaks down the resurgence of cell-free protein synthesis and its application across industries, including VTT’s research of cell-free proteins for pharma and the fashion industry. Plus, we discuss the importance of science writing to describe discoveries and communicate findings with funders and the public.

Sep 3, 2019 • 11min
Episode 02: Science Commune with Daniel Chen and Teemu Junttila
Science Commune is a segment of The Chain that goes beyond the science and explores the people making discoveries. We discuss their career paths, passions, and the people who inspired them along the way. Join Daniel Chen as he speaks with Teemu Junttila of Genentech about how his childhood in Finland inspired his work today with bispecific antibodies targeting solid tumors.

Aug 21, 2019 • 7min
Episode 01: International Collaboration Yields Therapeutic Protein with Genome Engineered CHO Cells. Bjørn Voldborg, Technical University
Bjørn Voldborg of the Technical University of Denmark speaks to CHI on July 18, 2019. He will be speaking during the Optimising Expression Platforms meeting at PEGS Europe, 18-22 November, in Lisbon, Portugal.Topics include the impact of big data on cell line engineering, his team’s success in producing Alpha-1 antitrypsin, the appeal of applied science and more.

Aug 21, 2019 • 1min
Episode 0: Welcome to The Chain
The Chain is a new podcast all about protein engineering and exploring the industry of biologics. We will learn from the experts what is new in the field and where it is heading. We will also be learning more about the people behind the papers, go into how they got to where they are today, and what inspires their work. We hope you’ll tune in to learn more about the science and minds that are changing the world one experiment at a time.


